sb 203580 has been researched along with beta-endorphin in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (beta-endorphin) | Trials (beta-endorphin) | Recent Studies (post-2010) (beta-endorphin) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 6,480 | 409 | 444 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brack, A; Hackel, D; Mousa, SA; Rittner, HL; Schäfer, M; Stein, C; Yamdeu, RS | 1 |
1 other study(ies) available for sb 203580 and beta-endorphin
Article | Year |
---|---|
Antinociception by neutrophil-derived opioid peptides in noninflamed tissue--role of hypertonicity and the perineurium.
Topics: Analgesia; Analgesics, Opioid; Analysis of Variance; Animals; Apoptosis; beta-Endorphin; Blotting, Western; Cell Count; Drug Administration Schedule; Enkephalin, Methionine; Flow Cytometry; Imidazoles; Immunohistochemistry; Inflammation; Male; N-Formylmethionine Leucyl-Phenylalanine; Necrosis; Neutrophils; Opioid Peptides; p38 Mitogen-Activated Protein Kinases; Pain Threshold; Peripheral Nerves; Phosphorylation; Pyridines; Radioimmunoassay; Rats; Rats, Wistar; Saline Solution, Hypertonic | 2009 |